Alex Zimmerman is the CEO of BrainSpec, an AI-backed neuroimaging startup from Mass General Brigham. Under her leadership, BrainSpec has achieved key milestones, including FDA clearance for its AI-powered virtual biopsy technology and the development of the first central brain chemistry database. Alex holds engineering degrees from Tufts and Brown and an MBA from Harvard.